AVALO THERAPEUTICS, INC. Basic Shares Outstanding (Weighted Average)
AVALO THERAPEUTICS, INC. (AVTX) reported Basic Shares Outstanding (Weighted Average) of 43.60 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- AVALO THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 43.60M shares, a 302.61% increase year-over-year.
- AVALO THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 20.11M shares, a 91.22% increase year-over-year.
- AVALO THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 18.23M shares, a 78.20% increase year-over-year.
- AVALO THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 14.00M shares, a 152.43% increase year-over-year.
- AVALO THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 13.40M shares, a 202.86% increase from fiscal 2024.
- AVALO THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 4.43M shares, a 1493.70% increase from fiscal 2023.
- AVALO THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 277.73K shares, a 608.45% increase from fiscal 2022.
- AVALO THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 39.20K shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 43.60M shares 10-Q · filed 2026-08-06 | 31.92M shares 10-Q · filed 2026-08-06 | 27.31M shares derived: average of 3 quarters · filed 2026-08-06 | 23.99M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | 20.11M shares 10-Q · filed 2026-05-13 | 19.17M shares derived: average of 2 quarters · filed 2026-05-13 | 17.45M shares derived: average of 3 quarters · filed 2026-05-13 | 15.79M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | 18.23M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | 16.12M shares derived: average of 2 quarters · filed 2026-03-23 | 14.35M shares derived: average of 3 quarters · filed 2026-08-06 | 13.40M shares 10-K · filed 2026-03-23 | ||||
| 2025-09-30 | 14.00M shares 10-Q · filed 2025-11-06 | 12.42M shares derived: average of 2 quarters · filed 2026-08-06 | 11.80M shares 10-Q · filed 2025-11-06 | 11.39M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | 10.83M shares 10-Q · filed 2026-08-06 | 10.67M shares 10-Q · filed 2026-08-06 | 10.53M shares derived: average of 3 quarters · filed 2026-08-06 | 9.28M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | 10.51M shares 10-Q · filed 2026-05-13 | 10.37M shares derived: average of 2 quarters · filed 2026-05-13 | 8.76M shares derived: average of 3 quarters · filed 2026-05-13 | 6.83M shares derived: average of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | 10.23M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | 7.89M shares derived: average of 2 quarters · filed 2026-03-23 | 5.60M shares derived: average of 3 quarters · filed 2026-03-23 | 4.43M shares 10-K · filed 2026-03-23 | ||||
| 2024-09-30 | 5.55M shares 10-Q · filed 2025-11-06 | 3.29M shares derived: average of 2 quarters · filed 2025-11-06 | 2.49M shares 10-Q · filed 2025-11-06 | 2.06M shares derived: average of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | 1.03M shares 10-Q · filed 2025-08-07 | 946.76K shares 10-Q · filed 2025-08-07 | 900.30K shares derived: average of 3 quarters · filed 2025-08-07 | 723.94K shares derived: average of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | 859.38K shares 10-Q · filed 2025-05-12 | 833.38K shares derived: average of 2 quarters · filed 2025-05-12 | 620.54K shares derived: average of 3 quarters · filed 2025-05-12 | 479.96K shares derived: average of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | 807.39K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | 501.12K shares derived: average of 2 quarters · filed 2025-03-20 | 353.49K shares derived: average of 3 quarters · filed 2025-03-20 | 277.73K shares 10-K · filed 2025-03-20 | ||||
| 2023-09-30 | 194.85K shares 10-Q · filed 2024-11-07 | 46.76M shares 10-Q · filed 2023-11-09 | 126.53K shares derived: average of 2 quarters · filed 2024-11-07 | 101.17K shares 10-Q · filed 2024-11-07 | 24.28M shares 10-Q · filed 2023-11-09 | -6.94M shares derived: average of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | 58.22K shares 10-Q · filed 2024-08-12 | 13.97M shares 10-Q · filed 2023-08-03 | 53.56K shares 10-Q · filed 2024-08-12 | 12.85M shares 10-Q · filed 2023-08-03 | -9.32M shares derived: average of 3 quarters · filed 2024-08-12 | -4.63M shares derived: average of 4 quarters · filed 2024-08-12 | ||
| 2023-03-31 | 48.84K shares 10-Q/A · filed 2024-07-11 | 11.72M shares 10-Q · filed 2023-05-04 | -14.00M shares derived: average of 2 quarters · filed 2024-07-11 | -6.20M shares derived: average of 3 quarters · filed 2024-07-11 | -2.30M shares derived: average of 4 quarters · filed 2024-07-11 | |||
| 2022-12-31 | -28.06M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -9.32M shares derived: average of 2 quarters · filed 2024-03-29 | -3.08M shares derived: average of 3 quarters · filed 2024-03-29 | 39.20K shares 10-K · filed 2024-03-29 | 9.41M shares 10-K · filed 2023-03-29 | |||
| 2022-09-30 | 9.41M shares 10-Q · filed 2023-11-09 | 9.41M shares derived: average of 2 quarters · filed 2023-11-09 | 9.40M shares 10-Q · filed 2023-11-09 | |||||
| 2022-06-30 | 9.40M shares 10-Q · filed 2023-08-03 | 9.40M shares 10-Q · filed 2023-08-03 | ||||||
| 2022-03-31 | 9.40M shares 10-Q · filed 2023-05-04 | |||||||
| 2018-12-31 | 40.85M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | 37.75M shares derived: average of 2 quarters · filed 2019-03-18 | 34.77M shares 10-K · filed 2019-03-18 | |||||
| 2018-09-30 | 34.65M shares 10-Q · filed 2018-11-13 | 32.75M shares 10-Q · filed 2018-11-13 | ||||||
| 2017-12-31 | 28.78M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | 25.08M shares derived: average of 2 quarters · filed 2019-03-18 | 18.41M shares 10-K · filed 2019-03-18 | |||||
| 2017-09-30 | 21.38M shares 10-Q · filed 2018-11-13 | 14.95M shares 10-Q · filed 2018-11-13 | ||||||
| 2016-12-31 | 9.26M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | 9.01M shares derived: average of 2 quarters · filed 2018-04-02 | 8.83M shares 10-K · filed 2018-04-02 | |||||
| 2016-09-30 | 8.76M shares 10-Q · filed 2017-11-07 | 8.69M shares 10-Q · filed 2017-11-07 | ||||||
| 2015-12-31 | 2.23M shares 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |